Company
Medibio Limited
Headquarters: Melbourne, VIC, Australia
CEO: Mr. Claude Solitario
Market Cap
A$6.1 Million
AUD as of Jan. 1, 2024
US$4.2 Million
Medibio Limited Categories
Australia Healthcare Health Information ServicesAustralia Healthcare Australia Health Information Services
Top Competitors by Market Capitalization
Industry: Health Information Services
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $34.86 B |
| Veeva Systems Inc. | $29.97 B |
| M3, Inc. | $11.24 B |
| Change Healthcare Inc. | $9.03 B |
| Signify Health, Inc. | $8.38 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Medibio Limited, a health technology company, researches, develops, and commercializes mental health technology to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. It has a clinical trial agreement with MedBridge Healthcare LLC to support sleep analysis of depressive burden (SADB) trial. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Medibio Limited has the following listings and related stock indices.
Stock: ASX: MEB wb_incandescent